Evidence map›Paper›PMID 40691232›Full record

ArticleScientific reports2025

Comparative biochemical properties of recombinant goat and calf chymosins and their implications in dairy processing.

Zhiger Akishev, Madina Auyez, Annelya Tursunbekova, Bekbolat Khassenov

Abstract readComparative Study
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhiger AkishevNational Center for Biotechnology, 13/5 Korgalzhyn Road, Astana, 010000, Kazakhstan.
Madina AuyezNational Center for Biotechnology, 13/5 Korgalzhyn Road, Astana, 010000, Kazakhstan.
Annelya TursunbekovaNational Center for Biotechnology, 13/5 Korgalzhyn Road, Astana, 010000, Kazakhstan.
Bekbolat KhassenovNational Center for Biotechnology, 13/5 Korgalzhyn Road, Astana, 010000, Kazakhstan. khassenov@biocenter.kz.

Funding

Ministry of Agriculture of the Republic of Kazakhstan BR10764998Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan АР19678941
6 · The paper itself

Abstract

The nutritional and functional properties of goat milk are well-established. However, the use of camel and calf-derived chymosins during cheese making from goat milk results in relatively low productivity. This study aimed to produce recombinant goat chymosin and investigate its biochemical properties and milk-clotting activity in goat and cow milk. To achieve this, recombinant goat chymosin was successfully expressed in Pichia pastoris, yielding 148,000 units/L of enzyme activity. Recombinant goat chymosin has exhibited maximum enzyme activity at 60 °C in both milk types, whereas recombinant calf chymosin showed maximum activity at 65 °C for goat milk and 75 °C for cow milk. Moreover, goat chymosin exhibited 13.6% higher activity in goat milk than that in cow milk. Both the enzymes efficiently clot sheep, cow, and camel milk but exhibited low activity against mare milk. The milk-clotting activity of both the enzymes was remarkably influenced by the calcium chloride concentration. To our knowledge, this study is the first to compare the biochemical properties of recombinant goat and calf chymosin in goat milk. The high specific activity of recombinant goat chymosin in goat milk suggests its potential as an effective milk-clotting enzyme in goat milk cheese production.

Indexed as

ChymosinMilkAnimalsCamelusCattleCheeseFood HandlingGoatsRecombinant ProteinsSaccharomycetalesSheepChymosinRecombinant ProteinsChymosinGoat milkMilk-clotting activityPichia pastorisRecombinant DNA

Identifiers

PMID40691232
PMCPMC12280187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.